Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bruker Corporation - Common Stock (NQ:BRKR)

40.55 -1.64 (-3.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bruker Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit
1 Healthcare Stock for Long-Term Investors and 2 to Question
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
Alpha Buying: When Leadership Buys, Should You Follow?
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
1 Cash-Producing Stock to Target This Week and 2 to Ignore
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Topics Economy
A Glimpse Into The Expert Outlook On Bruker Through 9 Analysts
Via Benzinga
Bruker Experiences Growth in Semiconductor Advanced Packaging Market Fueled by AI Demands
From Bruker Corporation
Via Business Wire
Q1 Earnings Outperformers: Bruker (NASDAQ:BRKR) And The Rest Of The Research Tools & Consumables Stocks
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Bruker (NASDAQ:BRKR) and its peers. 
Via StockStory
Topics Economy
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 to Keep Off Your Radar
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
BRKR Q1 Earnings Call: Tariffs and Funding Headwinds Offset by Product Innovation and Cost Actions
Scientific instrument company Bruker (NASDAQ:BRKR). reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $801.4 million. The company’s full-year... 
Via StockStory
Topics Economy World Trade
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection
From Bruker Corporation
Via Business Wire
Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics
From Bruker Corporation
Via Business Wire
Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics
From Bruker Corporation
Via Business Wire
Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity
From Bruker Corporation
Via Business Wire
Bruker Corporation to Present at the Jefferies Global Healthcare Conference
From Bruker Corporation
Via Business Wire
Bruker Launches Revolutionary timsOmniTM Mass Spectrometer
From Bruker Corporation
Via Business Wire
Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidence - at Speed, Depth, and Scale
From Bruker Corporation
Via Business Wire
Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology
From Bruker Corporation
Via Business Wire
Expert Outlook: Bruker Through The Eyes Of 8 Analysts
Via Benzinga
This Guidewire Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Via Benzinga
Bruker Announces Quarterly Dividend
From Bruker Corporation
Via Business Wire
Bruker and 10x Genomics Reach Global Settlement of Patent Litigation
From Bruker Corporation
Via Business Wire
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
2 Stocks Under $50 to Target This Week and 1 to Avoid
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
Bruker’s (NASDAQ:BRKR) Q1 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations
Scientific instrument company Bruker (NASDAQ:BRKR). reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $801.4 million. The company’s full-year... 
Via StockStory
Bruker Reports First Quarter 2025 Financial Results
From Bruker Corporation
Via Business Wire
Bruker (BRKR) Reports Q1: Everything You Need To Know Ahead Of Earnings
Scientific instrument company Bruker (NASDAQ:BRKR). will be reporting earnings tomorrow morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025
From Bruker Corporation
Via Business Wire
Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis
From Bruker Corporation
Via Business Wire
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 to Question
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.